SVG Sprites

Press

Press Releases 08.02.2021

On Medicare Anniversary, Members of Congress, Seniors, Veterans, Labor, Tribal Leaders Call on Senate to Allow Medicare to Negotiate Drug Prices

On the anniversary of Medicare, Lower Drug Prices Now is joining Members of Congress, seniors, veterans, labor leaders, tribal leaders, faith leaders, patients and local organizers to hold 18 events across the country calling on the Senate to allow Medicare to negotiate drug prices in the budget reconciliation bill currently being negotiated.

LDPN in the News 08.02.2021

WCTV: Florida Alliance for Retired Americans pushes for lower prescription drug prices

The Florida Alliance for Retired Americans celebrated the 56th birthday of Medicare and Medicaid on Friday; the group is calling on Congress to lower prescription drug prices.

Press Releases 07.29.2021

Medicare rebate rule can’t be the end of action to lower drug prices

Delaying the Medicare rebate rule is a step in the right direction for patients struggling to afford their prescription medication. But preventing cost-shifting is not a substitute for real reforms that rein in drug corporations’ monopoly power to raise prices anytime they want. 

LDPN in the News 07.23.2021

Times News Online: Legislators – U.S. Rep. Susan Wild

Wild has sent a letter to Democratic leadership urging them to include Medicare negotiation power in the upcoming reconciliation bill.

Press Releases 07.21.2021

The opioid settlement makes a mockery of justice.

This settlement makes a mockery of justice. While four of the most profitable drug corporations in the world agree to share a fraction of their profits with victims of opioids, not one of the executives responsible for this epidemic is being held accountable.

LDPN in the News 07.21.2021

Up North News: Drug Costs Are Skyrocketing. Congress Must Step In.

A Green Bay resident writes in support of HR3, a Democratic bill that would enact several measures to lower drug costs.

LDPN in the News 07.19.2021

Fierce Pharma: Pharma Congress has a ‘time-limited window’ to shake up drug pricing, employers, health groups say

A chance for meaningful drug pricing reform is upon us, dozens of purchasers, healthcare and employer groups contend. But Congress needs to capitalize on its “time-limited” opportunity, or the problem could stagnate or worsen.

Thank You for standing with us to put people before Pharma Profits!

Join our campaign, endorse our principles